ALNY logo

Alnylam Pharmaceuticals (ALNY)

Profile

Full Name

Alnylam Pharmaceuticals, Inc.

Ticker Symbol

ALNY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 1, 2004

Indexes

Not included

Website

http://www.alnylam.com

Employees

2230

Key Details

Price

$233.18(-2.85%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.25B(+22.97% YoY)

Annual EPS

-$2.18(+38.07% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$233.18
ALNY price is $233.18

30-Day Relative Volume

1.09
ALNY 30-day relative volume is 1.09

Price Performance

Price Today change

-2.85%
ALNY price is down -2.85% today

Price YTD change

-0.91%
ALNY price is down -0.91% since January 1st

Price 1-year change

+57.87%
ALNY price is up +57.87% year-on-year

Price 3-year change

+39.34%
ALNY price is up +39.34% over the past 3 years

Price Range

Price All-time high

$304.39
ALNY price is currently -23.40% below its historical high of $304.39

Price 3-year low

$117.58
ALNY price is currently +98.31% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$30.19B
ALNY market capitalization is $30.19 billion

Market cap 3-year change

+49.42%
ALNY market capitalization is up +49.42% over the past 3 years

Market cap All-time high

$38.52B
ALNY market capitalization is currently -21.64% below its historical high of $38.52 billion

Market cap sector rank

96.63%
ALNY market capitalization is higher than 96.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.37%
ALNY shares outstanding is up +2.37% year-on-year

Shares Outstanding 3-Year Change

+7.23%
ALNY shares outstanding is up +7.23% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.87
ALNY beta is 0.87

200-day SMA

$259.15
ALNY price is currently -10.02% below its 200-day simple moving average

50-day SMA

$254.40
ALNY price is currently -8.34% below its 50-day simple moving average

RSI

45.75
ALNY 14-day relative strength index is 45.75

Volume

1.09
ALNY 30-day relative volume is 1.09

ATR

$17.14
ALNY average true range is $17.14

10-day Historical Volatility

92.09%
ALNY 10-day historical volatility is 92.09%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.25B
ALNY annual revenue is $2.25 billion

Revenue Analysts estimate

$2.89B
ALNY annual revenue is currently -22.14% lower than the consensus analysts' forecast

Revenue 1-year change

+22.97%
ALNY annual revenue is up +22.97% year-on-year

Revenue Sector rank

85.89%
ALNY annual revenue is higher than 85.89% of companies in Healthcare sector

EPS

EPS

-$2.18
ALNY annual earnings per share is -$2.18

EPS Analysts estimate

$0.81
ALNY annual earnings per share is currently -369.40% lower than the consensus analysts' forecast

EPS 1-year change

+38.07%
ALNY annual earnings per share is up +38.07% year-on-year

EPS Sector rank

36.81%
ALNY annual earnings per share is higher than 36.81% of companies in Healthcare sector

Profit

Gross profit

$1.92B
ALNY annual gross profit is $1.92 billion

Gross margin

85.62%
ALNY annual gross profit margin is 85.62%

Operating profit

-$176.88M
ALNY annual operating income is -$176.88 million

Operating margin

-7.87%
ALNY annual operating profit margin is -7.87%

Net income

-$278.16M
ALNY annual net profit is -$278.16 million

Net margin

-12.37%
ALNY annual net profit margin is -12.37%

Expenses

Total expenses

$2.43B
ALNY annual total expenses is $2.43 billion

Operating expenses

$2.10B
ALNY annual total operating expenses is $2.10 billion

Cost of goods sold

$323.37M
ALNY annual cost of goods sold is $323.37 million

Selling, general & administrative expenses

$975.53M
ALNY annual SGA is $975.53 million

Depreciation and amortization

$56.67M
ALNY annual depreciation & amortization is $56.67 million

Interest expense

$141.86M
ALNY annual interest expense is $141.86 million

Income tax

-$99.22M
ALNY annual income tax is -$99.22 million

EBIT & EBITDA

EBIT

-$235.52M
ALNY annual earnings before interest & taxes is -$235.52 million

EBITDA

-$178.85M
ALNY annual EBITDA is -$178.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.24B
ALNY annual total assets is $4.24 billion

Non current assets

$944.70M
ALNY annual long term assets is $944.70 million

Current assets

$3.30B
ALNY annual total current assets is $3.30 billion

Cash and cash equivalents

$966.43M
ALNY annual cash & cash equivalents is $966.43 million

Accounts receivable

$405.31M
ALNY annual accounts receivable is $405.31 million

Inventory

$78.51M
ALNY annual inventory is $78.51 million

Liabilities

Total liabilities

$4.17B
ALNY annual total liabilities is $4.17 billion

Long term liabilities

$2.99B
ALNY annual total long term liabilities is $2.99 billion

Current liabilities

$1.19B
ALNY annual total current liabilities is $1.19 billion

Accounts payable

$88.42M
ALNY annual accounts payable is $88.42 million

Debt

Total debt

$1.30B
ALNY annual total debt is $1.30 billion

Total debt 1-year change

-0.72%
ALNY annual total debt is down -0.72% year-on-year

Long term debt

$1.25B
ALNY annual long term debt is $1.25 billion

Short term debt

$41.89M
ALNY annual short term debt is $41.89 million

Equity & Capital

Shareholders equity

$67.09M
ALNY annual stockholders equity is $67.09 million

Book value

$67.09M
ALNY annual book value is $67.09 million

Retained earnings

-$7.29B
ALNY annual retained earnings is -$7.29 billion

Working capital

$2.11B
ALNY annual working capital is $2.11 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.31M
ALNY annual cash flow from operations is -$8.31 million

Cash from operations 1-year change

-107.98%
ALNY annual cash flow from operations is down -107.98% year-on-year

Cash from investing

-$116.84M
ALNY annual cash flow from investing activities is -$116.84 million

Cash from investing 1-year change

+65.26%
ALNY annual cash flow from investing activities is up +65.26% year-on-year

Cash from financing

$294.16M
ALNY annual cash flow from financing activities is $294.16 million

Cash from financing 1-year change

+70.89%
ALNY annual cash flow from financing activities is up +70.89% year-on-year

CAPEX

CAPEX

$34.28M
ALNY annual capital expenditures is $34.28 million

CAPEX 1-year change

-44.9%
ALNY annual capital expenditures is down -44.9% year-on-year

Free Cash Flow

Free cash flow

-$42.59M
ALNY annual free cash flow is -$42.59 million

Free cash flow 1-year change

-201.54%
ALNY annual free cash flow is down -201.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

85.62%
ALNY annual gross profit margin is 85.62%

Operating margin

-7.87%
ALNY annual operating profit margin is -7.87%

Net margin

-12.37%
ALNY annual net profit margin is -12.37%

ROA & ROE

ROA

-6.89%
ALNY annual return on assets is -6.89%

ROE

-414.62%
ALNY annual return on equity is -414.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ALNY price to earnings ratio value is unknown

PE ratio Sector rank

-
ALNY price to earnings ratio is unknown

PB Ratio

PB ratio

449.95
ALNY price to book ratio is 449.95

PB ratio Sector rank

99.92%
ALNY price to book ratio is higher than 99.92% of companies in Healthcare sector

PS Ratio

PS ratio

13.43
ALNY price to sales ratio is 13.43

PS ratio Sector rank

83.21%
ALNY price to sales ratio is higher than 83.21% of companies in Healthcare sector

Enterprise value

Enterprise value

$30.52B
ALNY enterprise value is $30.52 billion

Enterprise value Sector rank

96.28%
ALNY enterprise value is higher than 96.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-192.77
ALNY EV/EBITDA is -192.77

EV/EBITDA Sector rank

0.61%
ALNY EV/EBITDA is higher than 0.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.78
ALNY annual current ratio is 2.78

Quick ratio

2.71
ALNY annual quick ratio is 2.71

Leverage

Debt to equity

15.27
ALNY annual debt to equity ratio is 15.27

Interest coverage ratio

-1.66
ALNY annual interest coverage ratio is -1.66

Risk & Stability

Piotroski F-Score

4
ALNY piotroski f-score is 4

Altman Z-Score

2.88
ALNY altman z-score is 2.88

Analyst ratings

Recent major analysts updates

Apr 11, 25 Morgan Stanley
Equal-Weight
Apr 9, 25 Needham
Buy
Apr 2, 25 HC Wainwright & Co.
Buy
Mar 31, 25 Stifel
Buy
Mar 31, 25 Scotiabank
Sector Outperform
Mar 31, 25 Redburn Atlantic
Buy
Mar 24, 25 JP Morgan
Overweight
Mar 21, 25 Wells Fargo
Equal-Weight
Mar 21, 25 Scotiabank
Sector Outperform
Mar 21, 25 RBC Capital
Outperform

Institutional Ownership

Similar stocks

CNC logo
Centene (CNC)
RMD logo
ResMed (RMD)
A logo
Agilent Technologies (A)
CAH logo
Cardinal Health (CAH)
GEHC logo
GE HealthCare Technologies (GEHC)
IDXX logo
IDEXX Laboratories (IDXX)
HUM logo
Humana (HUM)
IQV logo
IQVIA Holdings (IQV)
DXCM logo
DexCom (DXCM)
  • What is the ticker symbol for Alnylam Pharmaceuticals?
  • Does Alnylam Pharmaceuticals pay dividends?
  • What sector is Alnylam Pharmaceuticals in?
  • What industry is Alnylam Pharmaceuticals in?
  • What country is Alnylam Pharmaceuticals based in?
  • When did Alnylam Pharmaceuticals go public?
  • Is Alnylam Pharmaceuticals in the S&P 500?
  • Is Alnylam Pharmaceuticals in the NASDAQ 100?
  • Is Alnylam Pharmaceuticals in the Dow Jones?
  • When was Alnylam Pharmaceuticals's last earnings report?
  • When does Alnylam Pharmaceuticals report earnings?
  • Should I buy Alnylam Pharmaceuticals stock now?

What is the ticker symbol for Alnylam Pharmaceuticals?

The ticker symbol for Alnylam Pharmaceuticals is NASDAQ:ALNY

Does Alnylam Pharmaceuticals pay dividends?

No, Alnylam Pharmaceuticals does not pay dividends

What sector is Alnylam Pharmaceuticals in?

Alnylam Pharmaceuticals is in the Healthcare sector

What industry is Alnylam Pharmaceuticals in?

Alnylam Pharmaceuticals is in the Biotechnology industry

What country is Alnylam Pharmaceuticals based in?

Alnylam Pharmaceuticals is headquartered in United States

When did Alnylam Pharmaceuticals go public?

Alnylam Pharmaceuticals's initial public offering (IPO) was on June 1, 2004

Is Alnylam Pharmaceuticals in the S&P 500?

No, Alnylam Pharmaceuticals is not included in the S&P 500 index

Is Alnylam Pharmaceuticals in the NASDAQ 100?

No, Alnylam Pharmaceuticals is not included in the NASDAQ 100 index

Is Alnylam Pharmaceuticals in the Dow Jones?

No, Alnylam Pharmaceuticals is not included in the Dow Jones index

When was Alnylam Pharmaceuticals's last earnings report?

Alnylam Pharmaceuticals's most recent earnings report was on Feb 13, 2025

When does Alnylam Pharmaceuticals report earnings?

The next expected earnings date for Alnylam Pharmaceuticals is May 2, 2025

Should I buy Alnylam Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page